Aircraft Avionics MRO Research Report 2025: $10.3 Bn Market Share, Trends, Dynamics, Forecast, & Growth Analysis 2024-2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Aircraft Avionics MRO Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2025-2035” report... Read more.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs... Read more.
GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update
Remains on track to name a development candidate for a novel first-in-class neurology program targeting demyelinating diseases in 2026 Progresses discovery work... Read more.
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and... Read more.
Bullish releases December 2025 monthly metrics
CAYMAN ISLANDS–(BUSINESS WIRE)–Bullish (NYSE: BLSH), an institutionally focused global digital asset platform that provides market infrastructure and... Read more.
Carter’s, Inc. Provides Business Update
Preliminary fourth quarter and fiscal year 2025 consolidated net sales results Fourth quarter fiscal 2025: high single-digit percentage growth Fiscal year 2025:... Read more.
Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management... Read more.
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule... Read more.
ARDT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$ARDT #ARDT–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health,... Read more.
Linde Announces Fourth Quarter 2025 Earnings and Conference Call Schedule
WOKING, England–(BUSINESS WIRE)–Linde (Nasdaq: LIN) will release its fourth quarter 2025 financial results by 06:00 EST/midday CET on Thursday, February... Read more.